Obesity Featured Articles

  1. Why Data Integrity Still Matters — Even As Clinical Trials Evolve 12/4/2025

    Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.

  2. Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective 12/4/2025

    Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.

  3. Beyond the Acronyms: What Today's Trials Really Need From RTSM 12/4/2025

    Consider how resin selection, process optimization, and system qualification create scalable workflows that meet evolving regulatory and operational demands in modern biomanufacturing.

  4. Find The Right Operational Fit In Today's FSO–FSP Landscape 12/4/2025

    Clinical outsourcing is shifting from FSO vs. FSP debates to value-driven strategies. Success depends on alignment, governance, and oversight, with hybrid models rising among biotechs and structural FSP dominance in large pharma.

  5. Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors 12/4/2025

    Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

  6. Why Clinical Trial Demographics Don't Match Real-World Populations 12/4/2025

    Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.

  7. How Mobile Clinics Advance Diversity In Clinical Research 12/4/2025

    Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.

  8. Virtual Clinical Trials For Ophthalmic Measures 12/4/2025

    Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.

  9. Patient Input Is A Must — Even Under Time And Money Constraints 12/4/2025

    Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.

  10. From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials 12/3/2025

    Discover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.